American Journal of Cardiology
Volume 97, Issue 11 , Pages 1657-1660 , 1 June 2006

Evaluating the Optimal Activated Clotting Time During Carotid Artery Stenting

  • Jacqueline Saw, MD

      Affiliations

    • Vancouver General Hospital, Vancouver, British Columbia, Canada
    • Corresponding Author Information Corresponding author: Tel: 604-875-5547; fax: 604-875-5563.
    • ,
  • Christopher Bajzer, MD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • Ivan P. Casserly, MD

      Affiliations

    • Denver Veterans Affairs Medical Center and University of Colorado Health Sciences Center, Denver, Colorado
    • ,
  • Emilio Exaire, MD

      Affiliations

    • National Institute of Health, University of Mexico, Mexico City, Mexico.
    • ,
  • Cameron Haery, MD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • Ravish Sachar, MD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • David Lee, MD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • Alex Abou-Chebl, MD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • Jay S. Yadav, MD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, Ohio

Received 15 November 2005 ,Revised 20 December 2005 ,Accepted 20 December 2005.

References 

  1. American Heart Association . In: Heart Disease and Stroke Statistics—2003 Update . Dallas, Texas: American Heart Association; 2002;p. 15–18
  2. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et al  Protected carotid-artery stenting versus endarterectomy in high-risk patients . N Engl J Med . 2004;351:1493–1501
  3. Wholey MH , Al-Mubarek N . Updated review of the global carotid artery stent registry . Catheter Cardiovasc Interv . 2003;60:259–266
  4. Chew D, Bhatt D, Lincoff A, Moliterno D, Brener S, Wolski K, et al. Defining the optimal activated clotting time during percutaneous coronary intervention (aggregate results from 6 randomized, controlled trials) . Circulation . 2001;103:961–966
  5. Bush RL , Lin PH , Mureebe L , Zhou W , Peden EK , Lumsden AB . Routine bivalirudin use in percutaneous carotid interventions . J Endovasc Ther . 2005;12:521–522
  6. Lincoff A, Bittl J, Harrington R, Feit F, Kleiman NS, Jackman JD, et al  Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention . JAMA . 2003;289:853–863

PII: S0002-9149(06)00380-8

doi: 10.1016/j.amjcard.2005.12.062

American Journal of Cardiology
Volume 97, Issue 11 , Pages 1657-1660 , 1 June 2006

Article Tools

* Image Usage & Resolution